Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
February 2016
February 2016
NCT00134056Uploaded 10-09-2021
Access via NCI by Request
PDS UID: nci-data-485
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Files: NCT00134056-D1



Data DictionaryNCT00134056-D1-Data-Dictionary_0.pdf

DATANCT00134056-D1-Dataset_0.csv

OTHERREADME.pdf